APFID

Home > Latest News on ID > Interesting Papers

LOGIN
Global spread of carbapenem-resistant A. baumannii.
J Antimicrob Chemother. 2010;65(2):233-8
Date: 2010-02-03   Read: 156262

J Antimicrob Chemother. 2010 Feb;65(2):233-8

Global spread of carbapenem-resistant Acinetobacter baumannii

Higgins PG, Dammhayn C, Hackel M, Seifert H

OBJECTIVES: We have investigated the molecular epidemiology and distribution of carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii worldwide isolates (North and Latin America, Europe, Asia, South Africa and Australia).

METHODS: MICs were determined by broth microdilution and Etest. The presence of carbapenemase-encoding genes was investigated by PCR. Molecular epidemiology was performed by repetitive sequence-based PCR (rep-PCR; DiversiLab), sequence-type multiplex PCR and PFGE.

RESULTS: Imipenem non-susceptibility was associated with ISAba1 upstream of the intrinsic bla(OXA-51-like) or the acquired carbapenemase bla(OXA-23-like), bla(OXA-40-like) or bla(OXA-58-like). Isolates were grouped into eight distinct clusters including European clones I, II and III. European clone II was the largest (246 isolates) and most widespread group (USA, pan-Europe, Israel, Asia, Australia and South Africa).

CONCLUSIONS: The global dissemination of eight carbapenem-resistant lineages illustrates the success this organism has had in epidemic spread. The acquired OXA enzymes are widely distributed but are not the sole carbapenem resistance determinant in A. baumannii.



Next Worldwide dissemination of the blaOXA-23 carbapenemase gene of A. baumannii.
Emerg Infect Dis. 2010 Jan;16(1):35-40
2010-02-03 156595
Previous CA-MRSA in outpatients, United States, 1999-2006.
Emerg Infect Dis. 2009 Dec;15(12):1925-30
2010-01-06 157321
޴ٷΰ ΰ